Quote:

---

but aren't all of these patients likely taking these cheaper & available drugs as part of their standard of care treatment during the course of their disease? Wouldn't that have an effect on the fog that seems to be lingering in so many patients?

Read More: https://investorshangout.com/post/newpost/605...z6YsPJQtLP

---

I would assume that there will be a range of severity in long haulers. It could very well be that some of these cheaper treatments will be sufficient for some portion of the population, but others may need a more effective treatment.

At this point, I have no idea how effective leronlimab will be in long haulers. Dr. Yo and Dr. Patterson's comments seem to throw some cold water on it, but Dr. Kelley seems to think there is reason to believe it will be effective. I am hoping we can get Dr. Lelezari's input as well.